Diazepam precautions include the potential for respiratory depression to be increased under which condition?

Diazepam precautions include the potential for respiratory depression to be increased under which condition?

• A. It is always safe in hepatic failure
• B. It should never be used in patients with myasthenia gravis
• C. Respiratory depression is more likely when given rapidly or with other CNS depressants
• D. It has no placental transfer risk

Answer: (C)

The main idea is that benzodiazepines like diazepam can depress respiration, and this effect becomes much more likely when the drug is given quickly or when it’s combined with other central nervous system depressants. Diazepam enhances GABA activity in the brain, producing sedation and relaxation, but at higher levels it also dampens the brainstem areas that drive breathing. If you administer it rapidly, especially by IV, the drug spikes to high levels quickly, which can abruptly blunt the respiratory drive. When diazepam is used with other CNS depressants—such as alcohol, opioids, or other sedatives—their effects on the brain and respiratory centers add up, making significant respiratory depression more likely than with any single agent alone. Context helps: in patients with respiratory or pulmonary disease, or in the elderly, even standard doses can be riskier, and slower administration with careful monitoring is important. Diazepam can also accumulate and prolong sedation in liver impairment due to slower metabolism, and it readily crosses the placenta, which can affect a fetus. It’s not accurate to say it’s always safe in hepatic failure, never used in myasthenia gravis, or that it has no placental transfer risk; those points are not correct and don’t reflect how diazepam behaves pharmacologically.

The main idea is that benzodiazepines like diazepam can depress respiration, and this effect becomes much more likely when the drug is given quickly or when it’s combined with other central nervous system depressants. Diazepam enhances GABA activity in the brain, producing sedation and relaxation, but at higher levels it also dampens the brainstem areas that drive breathing. If you administer it rapidly, especially by IV, the drug spikes to high levels quickly, which can abruptly blunt the respiratory drive. When diazepam is used with other CNS depressants—such as alcohol, opioids, or other sedatives—their effects on the brain and respiratory centers add up, making significant respiratory depression more likely than with any single agent alone.

Context helps: in patients with respiratory or pulmonary disease, or in the elderly, even standard doses can be riskier, and slower administration with careful monitoring is important. Diazepam can also accumulate and prolong sedation in liver impairment due to slower metabolism, and it readily crosses the placenta, which can affect a fetus. It’s not accurate to say it’s always safe in hepatic failure, never used in myasthenia gravis, or that it has no placental transfer risk; those points are not correct and don’t reflect how diazepam behaves pharmacologically.